tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Abivax SA’s Obefazimod: Strong Phase 3 Results and Promising Market Potential Justify Buy Rating
PremiumRatingsAbivax SA’s Obefazimod: Strong Phase 3 Results and Promising Market Potential Justify Buy Rating
1M ago
Abivax announces trading resumption of shares on Euronext Paris
Premium
The Fly
Abivax announces trading resumption of shares on Euronext Paris
1M ago
Why Is Abivax Stock (ABVX) Up 490% Today? 
Premium
Market News
Why Is Abivax Stock (ABVX) Up 490% Today? 
2M ago
Abivax price target raised to $101 from $45 at LifeSci Capital
PremiumThe FlyAbivax price target raised to $101 from $45 at LifeSci Capital
2M ago
Abivax upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Abivax upgraded to Overweight from Equal Weight at Morgan Stanley
2M ago
Abivax upgraded to Overweight at Morgan Stanley after obefazimod data
Premium
The Fly
Abivax upgraded to Overweight at Morgan Stanley after obefazimod data
2M ago
Abivax SA – American Depositary Shares trading resumes
PremiumThe FlyAbivax SA – American Depositary Shares trading resumes
2M ago
Abivax Reports Positive Phase 3 Results for Ulcerative Colitis Treatment
Premium
Company Announcements
Abivax Reports Positive Phase 3 Results for Ulcerative Colitis Treatment
2M ago
Abivax says obefazimod met primary endpoint in ABTECT-1, ABTECT-2 trials
Premium
The Fly
Abivax says obefazimod met primary endpoint in ABTECT-1, ABTECT-2 trials
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100